Abstract:Background: As a main drug for diseased thrombus, some clinically used thrombolytic agents have various disadvantages, safer novel thrombolytic agents are of great demand. This study aimed to achieve high and efficient production of a fibrinolytic enzyme with superior enzymatic properties, by a combination strategy of codon optimization, gene dosage and process optimization in Komagataella phaffii (K. phaffii). Results: After codon optimization, the fibase from a marine Bacillus subtilis was expressed and secreted in K. phaffii GS115. Recombinant strains harboring different copies of the fib gene (fib-nc) were successfully obtained via Geneticin (0.25-4 mg/ml) screening on minimal dextrose selection plates and assessment via real-time quantitative PCR. The respective levels of fibase produced by strains expressing fib-5.4c, fib-6c, fib-8c, fib-9c, and fib-12c were 4428, 5781, 7323, 7930, and 2472 U/ml. Levels increased as the copy number increased from 4 to 9, but decreased dramatically at copy number 12. After high cell density fermentation optimization, the highest fibase activity of the strain expressing fib-9c was 7930 U/ml in a shake flask and increased to 12,690 U/ml after 3 days of continuous culture in a 5-L fermenter, which is one of the highest levels of production reported. The recombinant fibase was maximally active at pH 9.0 and 45 °C, and was remarkably stable at pH levels ranging from 5 to 10 and temperatures up to 50 °C. As a metal-dependent serine protease, fibase did not cause hemolysis in vitro and preferentially degraded fibrin directly. Conclusions: The combination of codon optimization, gene dosage, and process optimization described herein could be used for the expression of other therapeutic proteins difficult to express. The characteristics of the recombinant fibase suggest that it has potential applications for thrombosis prevention and therapy.

CHIMERIC FIBRINOLYTIC ENZYMES: PROGRESS AND PROSPECTIVE

Recent Advances of CREKA Peptide-Based Nanoplatforms in Biomedical Applications

Engineering and Characterization of a Chimeric Anti-platelet Glycoprotein Ibα Monoclonal Antibody and Preparation of Its Fab Fragment

Discovery and Preclinical Characterization of Fulacimstat (BAY 1142524), a Potent and Selective Chymase Inhibitor As a New Profibrinolytic Approach for Safe Thrombus Resolution

Biochemical Characterization of a Fibrinolytic Enzyme Composed of Multiple Fragments.

Engineering and Characterization of A Chimeric Anti-Platelet Glycoprotein Ib Alpha Monoclonal Antibody and Preparation of Its Fab Fragment

A Novel Fibrinolytic Protein From Pheretima vulgaris: Purification, Identification, Antithrombotic Evaluation, and Mechanisms Investigation

RESEARCH PROGRESS ON ANTICOAGULANT PROTEIN MOLECULAR

Purification and Biochemical Characterization of a Novel Fibrinolytic Enzyme from Culture Supernatant of Coprinus comatus

Progress in Study of Structure-Function Relationship and Protein Engineering of Plasminogen Activators

Construction And Characterization Of Trifunctional Single-Chain Urokinase-Type Plasminogen Activators - Trifunctional Plasminogen Activators

Development of Transient Recombinant Expression and Affinity Chromatography Systems for Human Fibrinogen

Integrating Metabolic Oligosaccharide Engineering and SPAAC Click Chemistry for Constructing Fibrinolytic Cell Surfaces

Purification and Characterization of a Fibrinolytic Enzyme from Marine Bacillus Velezensis Z01 and Assessment of Its Therapeutic Efficacy in Vivo.

Microbial Fibrinolytic Enzymes: an Overview of Source, Production, Properties, and Thrombolytic Activity in Vivo

An effective combination of codon optimization, gene dosage, and process optimization for high-level production of fibrinolytic enzyme in Komagataella phaffii (Pichia pastoris)

[Effect of a Novel Fibrinolytic Enzyme FA-I on Thrombosis and Thrombolysis].

Construction and Expression of Chimeric Antithrombotics with Hirudin and RGD Sequence

Engineered microparticles and nanoparticles for fibrinolysis

Diversity and Application of Microbial Fibrinolytic Enzymes

Purification and Characterization of a Novel Anticoagulant and Fibrinolytic Enzyme Produced by Endophytic Bacterium Paenibacillus Polymyxa EJS-3